Counter-drug sea drones utilized by Navy as Trump ramps up military resources at the border
The Navy has launched a new operation to interdict drug smugglers by sea that will rely on autonomous sea drones as President ...
FDA Opens Up A New Path To The U.S. Market For This Under 30 Biotech Startup
More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...
Poilievre says the Charter supports locking up drug kingpins without using the notwithstanding clause
OTTAWA — Conservative Leader Pierre Poilievre says he’s not worried about the Charter of Rights and Freedoms getting in the ...
FiercePharma1d
Supernus' 4th try proves the charm with long-awaited FDA approval for Parkinson's infusion pump Onapgo
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
With FDA approval, Genentech turns eye implant's focus to diabetes
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Business Wire1d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
Hosted on MSN1d
China tariffs could drive up drug prices and spur shortages in the U.S.
President Trump’s tariffs on China could increase drug prices and spur shortages across the U.S. as a trade war looms. NBC ...
Trump’s China tariffs are likely to drive up drug prices and spur shortages
President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...
FiercePharma15h
With recent launches and more to come, Amgen's biosimilar business is trending up
After recent launches of biosimilar versions of Eylea and Stelara, Amgen projects its biosimilar sales will reach $4 billion ...
STAT5d
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
United Therapeutics Says FDA Clears IND For The UKidney Xenotransplantation Clinical Trial
United Therapeutics Corp. (UTHR), a public benefit corporation, announced Monday that the U.S. Food and Drug Administration (FDA) has ...